CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2017	Jun. 30, 2017
Current Assets:
Cash and cash equivalents	$ 42,959,290	$ 43,393,570
Marketable securities	96,675,151	111,508,225
Accounts receivable, net of allowance for doubtful accounts of $12,589 at September 30, 2017 and $9,371 at June 30, 2017	427,177	488,723
Inventory	527,685	580,016
Other receivables	27,371	13,428
Prepaid expenses	5,109,855	891,284
Other current assets	1,637,356	422,916
Total current assets	147,363,885	157,298,162
Property and equipment, net of accumulated depreciation of $29,877,759 and $29,560,955 at September 30, 2017 and June 30, 2017, respectively	5,965,459	5,245,230
Other long-term assets	30,000	30,000
Total Assets	153,359,344	162,573,392
Current Liabilities:
Accounts payable and accrued expenses	33,397,939	31,366,976
Warrant liabilities	165,842,874	90,706,206
Deferred revenues	154,173	170,967
Total current liabilities	199,394,986	122,244,149
Convertible senior notes – net of unamortized debt issuance costs of $346,665 at September 30, 2017 and $1,915,781 at June 30, 2017	19,653,335	98,084,219
Other liabilities	1,699,206	1,708,272
Commitments and Contingencies (Note 13)
Stockholders’ Deficit:
Common stock, $.01 par value; authorized 250,000,000 shares; issued 152,055,301 shares and outstanding 152,020,576 shares at September 30, 2017; issued 110,344,643 shares and outstanding 110,309,918 shares at June 30, 2017	1,520,552	1,103,446
Capital contributed in excess of par	573,137,509	462,666,366
Treasury stock, at cost: 34,725 shares at September 30, 2017 and at June 30, 2017	(458,370)	(458,370)
Accumulated deficit	(640,455,447)	(521,710,899)
Accumulated other comprehensive loss	(343,710)	(302,710)
Total Immunomedics, Inc. stockholders' deficit	(66,599,466)	(58,692,167)
Noncontrolling interest in subsidiary	(788,717)	(771,081)
Total stockholders’ deficit	(67,388,183)	(59,463,248)
Total Liabilities and Stockholders' Deficit	153,359,344	162,573,392
Convertible preferred stock
Stockholders’ Deficit:
Convertible preferred stock, $.01 par value; authorized 10,000,000 shares; no shares issued and outstanding at September 30, 2017 and 1,000,000 shares issued and outstanding at June 30, 2017		$ 10,000

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.